Literature DB >> 31627932

What is an adequate margin for infiltrative soft-tissue sarcomas?

Tomohiro Fujiwara1, Jonathan Stevenson2, Michael Parry2, Yusuke Tsuda2, Kim Tsoi2, Lee Jeys2.   

Abstract

OBJECTIVES: What constitutes an adequate margin of resection for infiltrative subtypes of soft-tissue sarcomas remains unclear. We aimed to determine the prognostic significance of the margin in millimetres for myxofibrosarcoma (MFS) and undifferentiated pleomorphic sarcoma (UPS).
METHODS: 305 patients diagnosed with either a high-grade, localised MFS (n = 98) or UPS (n = 207) were included. The relationship of closest margin in millimetres to viable tumour and oncological outcomes was analysed.
RESULTS: The overall local recurrence (LR) rate for all patients were 12%: 19% with positive margin and 10% with negative margin (p = 0.051). The LR rate was similar in patients with negative but <10 mm margin; 13%, 6%, 15%, 17% with 0.1-0.9 mm, 1.0-1.9 mm, 2.0-4.9 mm, and 5.0-9.9 mm margin, respectively. However, the LR rate decreased to 3% if the margin was ≥10 mm. By the R- or R+1-classification, the 10-year cumulative probability of LR was 9%, 15%, 48% for R0, R1, R2 resections, respectively, which was not sensitive enough to stratify the LR risk in patients with negative margins. However, the cumulative probability of LR was significantly stratified by metric distance; the 10-year cumulative LR probability was 3%, 14%, 25% with ≥10.0 mm, 0.1-9.9 mm, and 0 mm, respectively (p = 0.026). A trend towards improved local control by adjuvant radiotherapy was seen in patients with 0-9.9 mm margin (p = 0.078).
CONCLUSION: The resection margin, when measured as a metric distance, correlates with a reduction in LR, and appears to be more significant on local control than radiotherapy. To minimise the risk of LR, a margin distance of at least 10 mm is advocated for MFS and UPS.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Margin; Myxofibrosarcoma; Prognosis; Soft-tissue sarcoma; Undifferentiated pleomorphic sarcoma

Year:  2019        PMID: 31627932     DOI: 10.1016/j.ejso.2019.10.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Undifferentiated Pleomorphic Sarcoma of the Duodenal Papilla: A Rare Case and Worth Discussing History.

Authors:  Jianlong Wang; Bin Liu; Jiachao Hou; Tao Li
Journal:  Front Surg       Date:  2022-07-06

2.  Time to Local Recurrence as a Predictor of Survival in Patients With Soft Tissue Sarcoma of the Extremity and Abdominothoracic Wall.

Authors:  Yao Liang; Tianhui Guo; Dongchun Hong; Wei Xiao; Zhiwei Zhou; Xing Zhang
Journal:  Front Oncol       Date:  2020-11-04       Impact factor: 6.244

3.  Soft-tissue reconstruction after soft-tissue sarcoma resection: the clinical outcomes of 24 patients.

Authors:  Hideo Hasegawa; Shinji Tsukamoto; Kanya Honoki; Takamasa Shimizu; Lorenzo Ferra; Costantino Errani; Spyros Sioutis; Andreas F Mavrogenis; Yasuhito Tanaka
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-02-20

4.  Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models.

Authors:  Maria Anna Smolle; Michiel van de Sande; Dario Callegaro; Jay Wunder; Andrew Hayes; Lukas Leitner; Marko Bergovec; Per-Ulf Tunn; Veroniek van Praag; Marta Fiocco; Joannis Panotopoulos; Madeleine Willegger; Reinhard Windhager; Sander P D Dijkstra; Winan J van Houdt; Jakob M Riedl; Michael Stotz; Armin Gerger; Martin Pichler; Herbert Stöger; Bernadette Liegl-Atzwanger; Josef Smolle; Dimosthenis Andreou; Andreas Leithner; Alessandro Gronchi; Rick L Haas; Joanna Szkandera
Journal:  Cancers (Basel)       Date:  2019-12-21       Impact factor: 6.639

5.  Local hyperthermia combined with chemotherapy for the treatment of multiple recurrences of undifferentiated pleomorphic sarcoma: A case report.

Authors:  Yi-Ting Zhou; Ruo-Yu Wang; Yao Zhang; Dong-Yi Li; Jian Yu
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

Review 6.  The Role of MRI-Guided Radiotherapy for Soft Tissue Sarcomas.

Authors:  Grace C Blitzer; Poonam Yadav; Zachary S Morris
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

7.  Development and validation of a prognostic nomogram for predicting the overall survival of myxofibrosarcoma patients: a large population-based study.

Authors:  Shuai Cao; Jie Li; Jun Zhang; Haopeng Li
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

8.  Intraoperative Near-Infrared Fluorescence Guided Surgery Using Indocyanine Green (ICG) for the Resection of Sarcomas May Reduce the Positive Margin Rate: An Extended Case Series.

Authors:  Marcus J Brookes; Corey D Chan; Fabio Nicoli; Timothy P Crowley; Kanishka M Ghosh; Thomas Beckingsale; Daniel Saleh; Petra Dildey; Sanjay Gupta; Maniram Ragbir; Kenneth S Rankin
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

9.  Late Local Recurrence and Metastasis in Soft Tissue Sarcoma of the Extremities and Trunk Wall: Better Outcome After Treatment of Late Events Compared with Early.

Authors:  Arvid von Konow; Iman Ghanei; Emelie Styring; Fredrik Vult von Steyern
Journal:  Ann Surg Oncol       Date:  2021-04-16       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.